CEACAM5 and cancer: By training the DL model on diverse optical interference and pattern datasets, the platform achieved a broad, multi-dimensional detection range for biomarkers related to sepsis (procalcitonin), COVID-19 (N-protein), and cancers (CEA, PSA).